Media center
STATEMENT: Canceling subscriptions, memberships to be easier under new FTC rules
NEW DATA: Large share of U.S. climate pollution comes from handful of coal and gas plants
STATEMENT: EPA releases $26 million to get the lead out of schools’ water
Contact our media team
Mark Morgenstein
Director of Media Relations, The Public Interest Network [email protected]
Are you a member of the media?
Join our media list
Topic/Campaign
Type
New Report: Product recalls, warnings and penalties all increased in 2023
Dangerous products connected to more than 550 injuries, 15 deaths, U.S. PIRG Education Fund analysis shows
STATEMENT: FDA says PFAS completely phased out of U.S. food packaging
Companies had used toxic ‘forever chemicals’ to protect paper, cardboard from grease
Colorado puts unprecedented restrictions on air pollution from lawn equipment
New policy limits summer use of gas-powered lawn mowers, phases out gas-powered leaf blowers on government property
Statement: Biden administration reins in deadly air pollution
New limits on soot will save thousands of lives
Parents and teachers call on EPA to ‘get the lead out’ at school
Groups representing millions of parents and teachers joined environmental and public health advocates to urge the EPA to get the lead out of drinking water at schools and child care centers.
STATEMENT: Biden administration takes steps to protect Arctic from drilling
Updated 2023 mid-hurricane season resource guide: data, resources & interview opportunities
The Atlantic hurricane season lasts from June 1 through November 30. This resource guide can help members of the media cover it more thoroughly and accurately.
NEWS RELEASE: Parents, environmentalists to Google: stop Chromebooks from expiring this summer
End of service for millions of school computers jeopardizes students’ educations
SCOTUS action will limit generic drug competition
U.S. Supreme Court on Monday declined to review a federal circuit court decision that imperils a critical method that many generic drug makers use to win approval. The court denied a petition of certiorari in Teva Pharmaceuticals USA, Inc. V GlaxoSmithKline LLC, Et. Al., allowing the divided lower court's decision to stand. This action can have dramatically limit competition from lower-priced generic and biosimilar medicines.
STATEMENT: EPA acts to protect drinking water from PFAS
New proposal would create first national limits on dangerous ‘forever chemicals’